Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Abbott selects new motilide as candidate for GI motility disorders

June 26, 1997

Anti-HBV nucleosides from Chong Kun Dang

June 23, 1997

Axcan to distribute Ursofalk in Canada

June 20, 1997

Combination therapy approved by FDA for H. pylori eradication

June 20, 1997

Synsorb Biotech receives U.S. patent coverage for treatment of diarrhea

June 18, 1997

Interferon/ribavirin compared to interferon and ribavirin monotherapy in chronic hepatitis C

June 17, 1997

Potent and selective beta3-adrenoceptor agonists claimed by Tokyo Tanabe

June 17, 1997

Vertex and Lilly join forces in hepatitis C drug development

June 16, 1997

SKB describes development of 5-HT4 antagonists for IBS

June 16, 1997

Abbott describes SAR leading to prokinetic motilides

June 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...